LOC342541 Inhibitors
LOC342541 inghibitors can consits of compounds like LY294002 and PD0325901 target critical intracellular signaling molecules, PI3K, and MEK, respectively. These molecules are integral to pathways like PI3K/AKT and MAPK/ERK, which govern various cellular responses, including proliferation, survival, and differentiation. The inhibition of these pathways by the aforementioned chemicals can lead to changes in the dynamics of proteins associated with these pathways, potentially altering the function or expression of LOC342541 if it is part of these signaling cascades.
Other molecules, such as Thapsigargin and Oligomycin A, specifically target cellular processes crucial for maintaining homeostasis, like calcium levels and ATP production. By disrupting these processes, they can induce a cellular environment that can modulate the function or stability of proteins including LOC342541. In addition, compounds that hinder cell cycle progression or cytoskeletal organization, such as ZM-447439 and Y-27632, can have profound effects on the regulation and function of proteins implicated in these cellular functions. These alterations can modulate the function or expression of LOC342541 by creating conditions that are unfavorable for its normal activity.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
A PI3K inhibitor that can disrupt the PI3K/AKT pathway, potentially affecting the activity or expression of LOC342541 if it is PI3K/AKT pathway-dependent. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
A p38 MAPK inhibitor that can alter the MAPK signaling pathway, potentially affecting the function of LOC342541 if it is a part of this pathway. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $65.00 $267.00 | 257 | |
An inhibitor of JNK that can modify the JNK signaling pathway, potentially influencing LOC342541 if it is JNK pathway-associated. | ||||||
ZM-447439 | 331771-20-1 | sc-200696 sc-200696A | 1 mg 10 mg | $150.00 $349.00 | 15 | |
An Aurora kinase inhibitor that can disrupt cell cycle progression, potentially affecting LOC342541 if it is involved in cell cycle regulation. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $182.00 $693.00 | 88 | |
A ROCK inhibitor that can affect cytoskeletal organization, potentially influencing LOC342541 if it plays a role in cell shape or motility. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
A SERCA pump inhibitor that disrupts calcium homeostasis, potentially affecting LOC342541 if it is calcium-dependent. | ||||||
BML-275 | 866405-64-3 | sc-200689 sc-200689A | 5 mg 25 mg | $94.00 $348.00 | 69 | |
An AMPK inhibitor that can affect metabolic signaling, potentially influencing LOC342541 function if it is involved in energy homeostasis. | ||||||
IKK-2 Inhibitor IV | 507475-17-4 | sc-203083 | 500 µg | $130.00 | 12 | |
An inhibitor of IKK that can modify NF-κB pathway signaling, potentially affecting LOC342541 if it is NF-κB pathway-related. | ||||||
SU 5402 | 215543-92-3 | sc-204308 sc-204308A | 1 mg 5 mg | $62.00 $96.00 | 36 | |
An FGFR inhibitor that can alter growth factor signaling, potentially affecting LOC342541 if it is involved in growth factor-mediated pathways. | ||||||
Oligomycin A | 579-13-5 | sc-201551 sc-201551A sc-201551B sc-201551C sc-201551D | 5 mg 25 mg 100 mg 500 mg 1 g | $175.00 $600.00 $1179.00 $5100.00 $9180.00 | 26 | |
An ATP synthase inhibitor that disrupts mitochondrial ATP production, potentially affecting LOC342541 if it is ATP-dependent. | ||||||